231 related articles for article (PubMed ID: 28018345)
1. Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases.
Peng S; Li C; Wang X; Liu X; Han C; Jin T; Liu S; Zhang X; Zhang H; He X; Xie X; Yu X; Wang C; Shan L; Fan C; Shan Z; Teng W
Front Immunol; 2016; 7():578. PubMed ID: 28018345
[TBL] [Abstract][Full Text] [Related]
2. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
4. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.
Dasu MR; Devaraj S; Park S; Jialal I
Diabetes Care; 2010 Apr; 33(4):861-8. PubMed ID: 20067962
[TBL] [Abstract][Full Text] [Related]
5. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
[No Abstract] [Full Text] [Related]
6. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
[TBL] [Abstract][Full Text] [Related]
7. Myeloid related proteins are up-regulated in autoimmune thyroid diseases and activate toll-like receptor 4 and pro-inflammatory cytokines in vitro.
Peng S; Sun X; Wang X; Wang H; Shan Z; Teng W; Li C
Int Immunopharmacol; 2018 Jun; 59():217-226. PubMed ID: 29656212
[TBL] [Abstract][Full Text] [Related]
8. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
[TBL] [Abstract][Full Text] [Related]
10. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
[TBL] [Abstract][Full Text] [Related]
11. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
12. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
Liu X; Wang C; Ye Z; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
[TBL] [Abstract][Full Text] [Related]
13. [Role of transduce molecules and modulatory factors of signal pathways of Toll-like receptor in inflammatory response of children with sepsis].
Yang WG; Li CR; He YX; Wang GB; Zu Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Sep; 20(9):561-4. PubMed ID: 18786322
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
15. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
16. Circulating Exosomes From Patients With Graves' Disease Induce an Inflammatory Immune Response.
Cui X; Huang M; Wang S; Zhao N; Huang T; Wang Z; Qiao J; Wang S; Shan Z; Teng W; Li Y
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33367747
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome.
Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN
Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938
[TBL] [Abstract][Full Text] [Related]
18. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
19. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.
Schaefer TM; Desouza K; Fahey JV; Beagley KW; Wira CR
Immunology; 2004 Jul; 112(3):428-36. PubMed ID: 15196211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]